New DopaFast App Aims to Combat Increasing Screen Time

4 weeks ago

VILNIUS, LITHUANIA / ACCESSWIRE / May 13, 2024 / Mobile application developer Kilo Payments, Inc. has unveiled a new screen…

AlzeCure Reports Anti-Inflammatory Effects with NeuroRestore ACD856 with Relevance to Alzheimer’s Leading to New Patent Application

4 weeks ago

STOCKHOLM, SWEDEN / ACCESSWIRE / May 13, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…

PMD Device Solutions Signs Letter of Intent for the Coala-Life Technology for 2 MSEK Per Year with Royalties

4 weeks ago

STOCKHOLM, SWEDEN / ACCESSWIRE / May 13, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) On May 13th, PMD Device Solutions (PMDS)…

KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending Value

4 weeks ago

Dr. Al Fayyadh at Harvard: We Leverage Technology to Tackle Global Health Challenges RIYADH, Saudi Arabia, May 11, 2024 (GLOBE…

Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives

4 weeks ago

Supports expansion of Tevogen’s ExacTcell™ platform toward additional clinical trialsBolsters a financial path to positive cashflow and minimizes dilution WARREN, N.J.,…

Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 weeks ago

SAN DIEGO, May 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May 10, 2024,…

Evaxion Receives Nasdaq Notification

4 weeks ago

COPENHAGEN, Denmark, May 10, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio…

Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates

4 weeks ago

JERUSALEM, May 10, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the…

Atrion Reports First Quarter 2024 Results

4 weeks ago

ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter…

Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

4 weeks ago

MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused…